| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $100.0M | +0.0% |
| R&D Expense | $10.0M | +79.4% |
| SG&A Expense | $7.6M | -17.8% |
| Operating Income | -$52.2M | -234.6% |
| Pre-tax Income | -$52.0M | -396.5% |
| Income Tax | -$9.5M | -1372.5% |
| Net Income | -$42.4M | -332.1% |
| EPS (Basic) | -$0.95 | -251.9% |
| EPS (Diluted) | -$0.95 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.9M | -8.1% |
| Short-term Investments | $15K | -99.9% |
| Accounts Receivable | $802K | +46.4% |
| Current Assets | $29.3M | -35.7% |
| Total Assets | $79.1M | -38.5% |
| Current Liabilities | $3.4M | +4.6% |
| Total Liabilities | $11.2M | -45.1% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.9M | +7.7% |
| Investing Cash Flow | $13.2M | +473.5% |
| Financing Cash Flow | $304K | — |
| -251.9% |
| Stockholders' Equity |
| $68.0M |
| -37.2% |